Switching to systemic therapy after locoregional treatment failure: Definition and best timing.
Ogasawara S, Ooka Y, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N.
Ogasawara S, et al. Among authors: chiba t.
Clin Mol Hepatol. 2020 Apr;26(2):155-162. doi: 10.3350/cmh.2019.0021n. Epub 2020 Jan 15.
Clin Mol Hepatol. 2020.
PMID: 31937081
Free PMC article.
Review.